News & Updates

Hypertension risk postpregnancy high among women with heart disease
Hypertension risk postpregnancy high among women with heart disease
16 May 2023

Women with heart disease are at increased risk of developing hypertension in the decades after pregnancy compared with those without heart disease, as reported in a retrospective study.

Hypertension risk postpregnancy high among women with heart disease
16 May 2023
Influenza vaccine wards off cardiovascular events, death in CAD patients
Influenza vaccine wards off cardiovascular events, death in CAD patients
10 May 2023 byStephen Padilla

A meta-analysis of randomized trials has revealed that influenza vaccination is effective at preventing all-cause mortality, cardiovascular mortality, major acute cardiovascular events, and acute coronary syndrome (ACS) among patients with coronary artery disease (CAD), particularly in those with ACS.

Influenza vaccine wards off cardiovascular events, death in CAD patients
10 May 2023
Mid-dose beta-blocker therapy tied to highest mortality reduction after AMI
Mid-dose beta-blocker therapy tied to highest mortality reduction after AMI
09 May 2023 byStephen Padilla

Use of any beta-blocker dose results in a significant decrease in mortality following acute myocardial infarction (AMI) when compared with no treatment, reports a study. Doses >25 percent to 50 percent of the currently recommended target dose (RTD) are associated with highest mortality reduction within the first year after AMI, indicating that higher doses are not required.

Mid-dose beta-blocker therapy tied to highest mortality reduction after AMI
09 May 2023
Bisphosphonate, denosumab not linked to acute cardiovascular risk
Bisphosphonate, denosumab not linked to acute cardiovascular risk
06 May 2023

Use of oral bisphosphonate or denosumab does not appear to increase the risk of cardiovascular events (CVEs), namely acute myocardial infarction, unstable angina, cerebrovascular accident, and transient ischemic attack, in persons with incident fracture, a study has shown.

Bisphosphonate, denosumab not linked to acute cardiovascular risk
06 May 2023
Preconception HBV history linked to congenital heart disease risk in offspring
Preconception HBV history linked to congenital heart disease risk in offspring
04 May 2023

Children born to mothers who had contracted hepatitis B virus (HBV) infection before pregnancy appear to be at increased risk of congenital heart diseases (CHDs), as reported in a study.

Preconception HBV history linked to congenital heart disease risk in offspring
04 May 2023